Director, Regulatory Affairs

pKiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most. /p pThe Director, Regulatory Affairs, reports to the Executive Director, Regulatory Affairs and Writing (US based) and provides strategic regulatory leadership for drug development and commercial project(s)/program(s). This role supports US and/or outside-US (OUS) regulatory submissions and health authority interactions and develops strategies to reduce risk and identify opportunities to accelerate development in line with corporate objectives and timelines. The Director combines strategic leadership with hands‑on support across early‑and late‑stage development and post‑approval lifecycle management and collaborates with internal and external stakeholders to execute program objectives in compliance with applicable regulations. /p pbThis role is based in Switzerland. /b /p h3Responsibilities (including, But Not Limited To) /h3 ul liProvide strategic regulatory leadership for assigned drug development and commercial programs, supporting US and/or OUS regulatory submissions, health authority interactions, and lifecycle management activities in line with corporate objectives and timelines. /li liExercise delegated regulatory decision‑making authority for assigned programs on behalf of the Swiss entity. /li liSupport interactions with US and/or OUS health authorities, including preparing for and contributing to meetings to facilitate timely review and approval of initial applications and subsequent submissions. /li liDevelop regulatory strategies to reduce risk, identify opportunities to accelerate development, and support post‑approval changes and lifecycle objectives for marketed products. /li liProvide leadership and hands‑on support to the regulatory team in managing, planning, coordinating, and preparing US and/or OUS regulatory submissions, including clinical trial applications (e.g., INDs and CTAs), marketing applications (e.g., BLAs and MAAs), drug master files, amendments, safety reports, annual updates, post‑approval supplements and variations, renewals, and other lifecycle maintenance submissions, as applicable. /li liInterpret and communicate regulatory expectations to internal and external stakeholders to execute program objectives in compliance with applicable regulations. /li liStrategic leadership and development of policies, procedures, and best practices commensurate with the requirements of a rapidly growing company. /li /ul h3Standout Skills For Impact /h3 ul liAbility to set regulatory strategies while taking a hands‑on approach to all regulatory activities. /li liStrong leadership and communication skills, with the ability to work across multiple functional areas in a matrixed team environment. /li liStrategic thinking that balances near‑term objectives with long‑term goals and outcomes. /li liStrong verbal and written communication skills, including the ability to clearly articulate regulatory viewpoints to a diverse audience. /li liAbility to thrive in a collaborative and fast‑paced team environment. /li /ul h3Qualifications And Experience /h3 ul liBS degree required; PharmD or PhD preferred. A minimum of 10 years of Regulatory Affairs experience within the biopharmaceutical industry is required. /li liStrong knowledge of regulatory requirements supporting clinical development, marketing applications, and post‑approval lifecycle management in the US and/or OUS markets. /li liPrior experience successfully supporting US and/or OUS marketing application submissions (e.g., BLAs and MAAs) and post‑approval regulatory activities, with experience across early- and late-stage development and commercial product lifecycle management. /li liExperience preparing and supporting US and/or OUS regulatory submissions, including clinical trial applications, safety reports, Investigator Brochures, DSURs, briefing packages, and other regulatory documents as required. /li liExperience supporting interactions with US and/or OUS health authorities. /li liExperience working with multiple functional areas in a matrixed team environment is required. /li liExperience with biologics drug development is highly desirable; experience in immunology/inflammation is a plus. /li liFamiliarity with eCTD and e-publishing systems for preparing regulatory submissions is a plus. /li liFluency in German Language. /li /ul pCompensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks. /p pPay Range /p pCHF210,800 - CHF231,000 CHF /p pKiniksa is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, transgender status, age, genetics, national origin, protected veteran status, or disability status, or any other legally protected category. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation. /p pKiniksa does not accept unsolicited resumes from staffing agencies or search firms. Any resumes submitted without a signed agreement will be considered property of Kiniksa, and no fees will be paid. /p #J-18808-Ljbffr